PROCEPT BioRobotics Corporation
PRCT
$49.96
$1.452.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.75% | 13.68% | 6.10% | 0.81% | -4.99% |
| Total Depreciation and Amortization | 31.61% | 37.48% | 61.77% | 72.26% | 45.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.27% | 69.35% | 30.02% | 22.63% | 19.38% |
| Change in Net Operating Assets | -39.78% | -80.90% | 5.73% | 34.89% | -29.91% |
| Cash from Operations | 19.60% | 8.14% | 15.47% | 16.04% | -6.41% |
| Capital Expenditure | 80.29% | 82.51% | 31.15% | -33.56% | -174.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.29% | 82.51% | 31.15% | -33.56% | -174.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.20% | 7.35% | -92.51% | 3,306.92% | 2,987.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.20% | 7.35% | -92.38% | 7,518.64% | 6,194.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.79% | 121.20% | -340.57% | 152.97% | 142.42% |